Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100%…
Today on Fox Business Varney & Company, David Bahnsen (The Bahnsen Group) was asked if the current market reminded him…
While the S&P 500 continues to move higher, the number of stocks participating to the upside continues to decline. In…
Stocks tumbled for the second-straight day Friday as a weaker-than-expected jobs report and a dismal forecast from Amazon added to…
There was no shortage of false claims and exaggerations offered by former president Donald Trump during his conversation with Elon…